PHARMACOLOGY

Oral anticoagulation therapy initiation in patients with atrial fibrillation in relation to world region of origin: a register-based nationwide study
Juliane Frydenlund, Jan Brink Valentin, Marie Norredam, Lars Frost, Sam Riahi, Kristian Hay Kragholm, Henrik Bøggild, Gregory Y H Lip, Søren Paaske Johnsen

Open Heart Mar 2024, 11 (1) e002544; DOI: 10.1136/openhrt-2023-002544
Multimorbidity in patients with atrial fibrillation
Michelle Lobeek, Melissa E Middeldorp, Isabelle C Van Gelder, Michiel Rienstra

Open Heart Mar 2024, 11 (1) e002641; DOI: 10.1136/openhrt-2024-002641
External validation and updating of prediction models of bleeding risk in patients with cancer receiving anticoagulants
EM Trinks-Roerdink, GJ Geersing, MEW Hemels, IC van Gelder, FA Klok, M van Smeden, FH Rutten, S van Doorn

Open Heart Apr 2023, 10 (1) e002273; DOI: 10.1136/openhrt-2023-002273
Association between perioperative statin treatment and short-term clinical outcomes following transcatheter aortic valve implantation: a retrospective cohort study
Geert Lefeber, Lauren Dautzenberg, Wilma Knol, Carla Huijbers, Michiel Voskuil, Adriaan O Kraaijeveld, Marcel Bouvy, Anthonius de Boer, Marielle Emmelot-Vonk, Huiberdina L Koek

Open Heart Oct 2023, 10 (2) e002348; DOI: 10.1136/openhrt-2023-002348
Fluoroquinolones do not provide added risk of out-of-hospital cardiac arrest: a nationwide study
Viktoría Ellenardóttir, Ruben Coronel, Fredrik Folke, Andrim Halili, Anojhaan Arulmurugananthavadivel, Saaima Parveen, Mikkel Porsborg Andersen, Morten Schou, Christian Torp-Pedersen, Gunnar Gislason, Talip E Eroglu

Open Heart Jan 2024, 11 (1) e002520; DOI: 10.1136/openhrt-2023-002520
Multispecialty multidisciplinary input into comorbidities along with treatment optimisation in heart failure reduces hospitalisation and clinic attendance
Hani Essa, Lauren Walker, Kevin Mohee, Chukwuemeka Oguguo, Homeyra Douglas, Matthew Kahn, Archana Rao, Julie Bellieu, Justine Hadcroft, Nick Hartshorne-Evans, Janet Bliss, Asangaedem Akpan, Christopher Wong, Daniel J Cuthbertson, Rajiv Sankaranarayanan

Open Heart Jul 2022, 9 (2) e001979; DOI: 10.1136/openhrt-2022-001979
Pharmacological treatment in patients with aortic dissection
Christian Smedberg, Rebecka Hultgren, Karin Leander, Johnny Steuer

Open Heart Nov 2022, 9 (2) e002082; DOI: 10.1136/openhrt-2022-002082
Four pillars of heart failure: contemporary pharmacological therapy for heart failure with reduced ejection fraction
Sam Straw, Melanie McGinlay, Klaus K Witte

Open Heart Mar 2021, 8 (1) e001585; DOI: 10.1136/openhrt-2021-001585
Icosapent ethyl: scientific and legal controversies
Gregory Curfman, Emile Shehada

Open Heart Apr 2021, 8 (1) e001616; DOI: 10.1136/openhrt-2021-001616
Type 2 myocardial infarction and myocardial injury: eligibility for novel medical therapy to derisk clinical trials
Robert Sykes, Michael Briscoe, Thomas Krysztofiak, Oliver Peck, Kenneth Mangion, Colin Berry

Open Heart Jun 2021, 8 (1) e001633; DOI: 10.1136/openhrt-2021-001633

Main menu

PHARMACOLOGY

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

PHARMACOLOGY

Pages